Researchers have predicted that cases of glaucoma, a common eye condition that can lead to blindness if not treated, are expected to increase around the world in the coming years.

Glaucoma is one of the leading causes of irreversible blindness worldwide, yet many people do not notice its symptoms early. Experts say regular eye check-ups are the only way to detect the condition ...

Open-angle glaucoma often has no symptoms until vision loss begins, so regular screening is important. You can use eye drops and laser therapy to slow the progression of open-angle glaucoma. Try using ...

Avisi Technologies, Inc., an ophthalmic medical device company advancing novel, sight-saving technologies, announces the closing of $10.7M in new financing. The Series A round was led by MedVenture ...

Sudden blurry vision in one eye can sometimes signal serious eye emergencies such as retinal detachment, eye stroke, glaucoma, or optic neuritis. Ophthalmologist Dr Neeraj Sanduja explains warning ...

A woman suffered "avoidable" sight loss after waiting two years for NHS cataract surgery in Wales. The woman endured 11 cancelled apppointments and failures in the management of her care during the ...

Johnson & Johnson , a worldwide leader in multiple myeloma therapies, today announced that the U.S. Food and Drug ...

This problem often begins subtly when the individual finds themselves brushing against the edge of a table or shoulder grazing a door frame more frequently than before. There are minor bruises that ...

The early part of the year brings not only cold weather, but also awareness for the “sneak thief of sight,” glaucoma. The devastation that the disease can bring is particularly challenging for African ...

A planned overnight sign replacement is set to shut down a key I‑495 ramp in Wareham on Feb. 12, tightening traffic as MassDOT reroutes drivers onto a multi‑step detour. The closure begins at 9 p.m.

Company launched TONMYA, approved by the FDA as a treatment for fibromyalgia, in November 2025 In post hoc analysis of the pivotal RESILIENT study, TONMYA produced rapid pain relief as early as Day 2 ...